View in EDS

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).

Saved in:
Bibliographic Details
Title: Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Authors: Gomez-Arteaga A; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. alg9117@med.cornell.edu., Orfali N; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; Department of Haematology, St James Hospital, Dublin, Ireland., Pasciolla M; Department of Pharmacy, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Baptiste A; Division of Hematology and Oncology, NewYork-Presbyterian Hospital Brooklyn Methodist Hospital, Brooklyn, NY, USA., Guindine I; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Hsu J; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Lin J; Division of Nephrology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; The Rogosin Institute, New York, NY, USA., Mayer SA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Phillips AA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Shore TB; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Simonson PD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., DiCarlo E; Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, USA., Yoon S; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA., Muthukumar T; Division of Nephrology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; The Rogosin Institute, New York, NY, USA., van Besien K; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Jul; Vol. 58 (7), pp. 835-838. Date of Electronic Publication: 2023 Apr 12.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37045941
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gomez-Arteaga+A%22">Gomez-Arteaga A</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. alg9117@med.cornell.edu.<br /><searchLink fieldCode="AU" term="%22Orfali+N%22">Orfali N</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; Department of Haematology, St James Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Pasciolla+M%22">Pasciolla M</searchLink>; Department of Pharmacy, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Baptiste+A%22">Baptiste A</searchLink>; Division of Hematology and Oncology, NewYork-Presbyterian Hospital Brooklyn Methodist Hospital, Brooklyn, NY, USA.<br /><searchLink fieldCode="AU" term="%22Guindine+I%22">Guindine I</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+J%22">Hsu J</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Division of Nephrology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; The Rogosin Institute, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mayer+SA%22">Mayer SA</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+AA%22">Phillips AA</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Shore+TB%22">Shore TB</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Simonson+PD%22">Simonson PD</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22DiCarlo+E%22">DiCarlo E</searchLink>; Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+S%22">Yoon S</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Muthukumar+T%22">Muthukumar T</searchLink>; Division of Nephrology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.; The Rogosin Institute, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22van+Besien+K%22">van Besien K</searchLink>; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2023 Jul; Vol. 58 (7), pp. 835-838. <i>Date of Electronic Publication: </i>2023 Apr 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37045941
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41409-023-01981-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 835
    Titles:
      – TitleFull: Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gomez-Arteaga A
      – PersonEntity:
          Name:
            NameFull: Orfali N
      – PersonEntity:
          Name:
            NameFull: Pasciolla M
      – PersonEntity:
          Name:
            NameFull: Baptiste A
      – PersonEntity:
          Name:
            NameFull: Guindine I
      – PersonEntity:
          Name:
            NameFull: Hsu J
      – PersonEntity:
          Name:
            NameFull: Lin J
      – PersonEntity:
          Name:
            NameFull: Mayer SA
      – PersonEntity:
          Name:
            NameFull: Phillips AA
      – PersonEntity:
          Name:
            NameFull: Shore TB
      – PersonEntity:
          Name:
            NameFull: Simonson PD
      – PersonEntity:
          Name:
            NameFull: DiCarlo E
      – PersonEntity:
          Name:
            NameFull: Yoon S
      – PersonEntity:
          Name:
            NameFull: Muthukumar T
      – PersonEntity:
          Name:
            NameFull: van Besien K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5365
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Bone marrow transplantation
              Type: main
ResultId 1